The 5 analysts offering 12-month price forecasts for Novan Inc have a median target of 30.00, with a high estimate of 70.00 and a low estimate of 16.00. The median estimate represents a +588.07% increase from the last price of 4.36.
Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.
What does novan Inc do? Novan, Inc. is a late-stage pharmaceutical company. The Company develops, produces, and sells nitric oxide-based products. Novan markets around the world.
Is novan a good investment? If you are looking for stocks with good return, Novan Inc can be a profitable investment option. Novan Inc quote is equal to 4.380 USD at 2021-12-18. ... With a 5-year investment, the revenue is expected to be around +542.11%.
Should I invest in Novn stock? Out of 3 analysts, 2 (66.67%) are recommending NOVN as a Strong Buy, 1 (33.33%) are recommending NOVN as a Buy,
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.